✦ LIBER ✦
Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: A Phase II study of AZD0837 in patients who are appropriate for but unable or unwilling to take vitamin K antagonist therapy
✍ Scribed by Gregory Y.H. Lip; Lars H. Rasmussen; S. Bertil Olsson; Sofia Zetterstrand; Christina Stahre; Anders Bylock; Maria Aunes-Jansson; Ulf Eriksson; Karin Wåhlander
- Book ID
- 116914600
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 659 KB
- Volume
- 127
- Category
- Article
- ISSN
- 0049-3848
No coin nor oath required. For personal study only.